Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (761-770 of 1,119) with videos related to

Pageof 112
Sort By:
Journal of the American College of Cardiology|September 2, 2025
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb eventsKausik K Ray, Michael Szarek, Deepak L Bhatt, et al.
Journal of the American Heart Association|December 14, 2022
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART StudyMaya S Sheth, Bing Yu, Anna Chu, et al.
European Heart Journal|February 10, 2009
Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunctionJorge A Wong, Shaun G Goodman, Raymond T Yan, et al.
The American Journal of Cardiology|May 26, 2009
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromesAlan J Bagnall, Shaun G Goodman, Keith A A Fox, et al.
American Heart Journal|October 8, 2013
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertensionDana Lee, Shaun G Goodman, Keith A A Fox, et al.
Journal of the American College of Cardiology|February 1, 2020
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMESShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
Diabetes Care|September 9, 2010
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI)Hwee Teoh, Manoela F B Braga, Amparo Casanova, et al.
Cell|August 23, 2006
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overloadSeiichi Oyadomari, Chi Yun, Edward A Fisher, et al.
American Heart Journal|January 28, 2010
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularizationEsam Elbarasi, Shaun G Goodman, Raymond T Yan, et al.
The Canadian Journal of Cardiology|July 3, 2017
A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven SafetyDavid Fitchett, Alice Cheng, Kim Connelly, et al.
Pageof 112

Showing results (761-770 of 1,119) with videos related to

Sort By:
Pageof 112
Journal of the American College of Cardiology|September 2, 2025
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb eventsKausik K Ray, Michael Szarek, Deepak L Bhatt, et al.
Journal of the American Heart Association|December 14, 2022
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART StudyMaya S Sheth, Bing Yu, Anna Chu, et al.
European Heart Journal|February 10, 2009
Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunctionJorge A Wong, Shaun G Goodman, Raymond T Yan, et al.
The American Journal of Cardiology|May 26, 2009
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromesAlan J Bagnall, Shaun G Goodman, Keith A A Fox, et al.
American Heart Journal|October 8, 2013
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertensionDana Lee, Shaun G Goodman, Keith A A Fox, et al.
Journal of the American College of Cardiology|February 1, 2020
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMESShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
Diabetes Care|September 9, 2010
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI)Hwee Teoh, Manoela F B Braga, Amparo Casanova, et al.
Cell|August 23, 2006
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overloadSeiichi Oyadomari, Chi Yun, Edward A Fisher, et al.
American Heart Journal|January 28, 2010
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularizationEsam Elbarasi, Shaun G Goodman, Raymond T Yan, et al.
The Canadian Journal of Cardiology|July 3, 2017
A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven SafetyDavid Fitchett, Alice Cheng, Kim Connelly, et al.
Pageof 112